Class III — Low Risk

Low risk — use of or exposure to this product is not likely to cause adverse health consequences.

cobas¿ EGFR Mutation Test epidermal growth factor receptor (EGFR) gene Recalled by Roche Molecular Systems, Inc. Due to False positive results for Exon 20 insertion mutations...

Date: January 13, 2015
Company: Roche Molecular Systems, Inc.
Status: Terminated
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Roche Molecular Systems, Inc. directly.

Affected Products

cobas¿ EGFR Mutation Test epidermal growth factor receptor (EGFR) gene DNA assay

Quantity: 190 kits

Why Was This Recalled?

False positive results for Exon 20 insertion mutations are being detected with the cobas¿ EGFR Mutation Test, kit batch T08661.

Where Was This Sold?

Foreign

About Roche Molecular Systems, Inc.

Roche Molecular Systems, Inc. has 42 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report